HealthStream, Inc. Announces Share Repurchase Program and Amends Credit Agreement

Key Highlights

• New Share Repurchase Program: Board of Directors has authorized repurchase of up to \$10 million of common stock.
• Amendment to Credit Agreement: Modifies terms to allow greater flexibility for restricted payments, including dividends and share repurchases.
• Potential Impact: These actions may directly affect shareholder value and the company’s leverage metrics.
• Termination Date: The repurchase program ends on the earlier of September 12, 2026 or once \$10 million is spent.

Details of the Material Events

1. Entry into Material Definitive Agreement: Amendment to Credit Facility

On March 13, 2026, HealthStream, Inc. (“the Company”) entered into the First Amendment to its Amended and Restated Revolving Credit Agreement with Truist Bank. This amendment makes several critical changes to the restricted payments provisions:

• Dividends and Share Repurchases: The amendment permits the Company to make restricted payments (including dividends and share repurchases) as long as, after such payments, the Company’s pro forma leverage ratio does not exceed 1.50:1.00 and no default or event of default has occurred or is continuing.
• Additional Restricted Payments: Allows further restricted payments up to an aggregate limit of \$50 million, provided no default or event of default is ongoing.
• Prior Limits: Previously, the aggregate restricted payments under these provisions were capped at \$50 million. The amendment clarifies the conditions and expands flexibility.

This increased flexibility gives HealthStream the ability to return more capital to shareholders, either through dividends or share buybacks, as long as leverage and default conditions are met. This could be price-sensitive information, as it may signal management’s confidence in the company’s financial position and future cash flows, and could affect future payout policies.

2. Other Events: Share Repurchase Program

On the same day, HealthStream announced via press release that its Board of Directors has approved a new share repurchase program. This program authorizes the repurchase of up to \$10 million in outstanding common stock, with no par value. The repurchase program will terminate either when the full \$10 million has been spent or by September 12, 2026, whichever is earlier.

• Price Sensitivity: Share repurchase programs are often viewed positively by investors, as they can signal management’s belief that the shares are undervalued and can directly increase earnings per share by reducing the number of shares outstanding. This announcement is likely to be price-sensitive and may positively impact the stock price.
• Recent Cash Dividends: The Company has been paying quarterly cash dividends on its common stock, with amounts ranging from approximately \$757,350 (Dec-23) to \$946,283 (May-25). This demonstrates an ongoing commitment to shareholder returns, which, combined with the buyback program, enhances investor confidence.
• Share Repurchase Amounts: Share repurchases have occurred in recent months, with amounts such as \$11,094,372 (May-25), \$7,013,708 (Jun-25), \$6,891,813 (Jul-25), \$2,499,964 (Nov-25), and \$4,999,897 (Jan-26). These figures show substantial activity, underscoring the seriousness of the repurchase program.

Shareholder Information and Potential Impact

• The enhanced flexibility in the credit agreement may allow HealthStream to increase dividends and carry out additional share repurchases beyond previous limits, subject to leverage and default conditions.
• The buyback program, in particular, is likely to have a direct impact on share price, as it tends to reduce the total number of shares outstanding, potentially increasing earnings per share and signaling confidence from management.
• Ongoing dividend payments and share repurchase activity demonstrate a strong shareholder return policy, which may be viewed favorably by the market.
• Investors should be aware that future financial performance, leverage ratios, and absence of default events will be critical to the continuation of these programs.

Corporate and Regulatory Information

• Trading Symbol: HSTM
• Exchange: Nasdaq Global Select Market
• Company Address: 500 11th Avenue North, Suite 850, Nashville, TN
• Filer CIK: 0001095565
• Emerging Growth Company: HealthStream is not an emerging growth company under SEC rules.

Press Release and Forward-Looking Statements

The press release announcing the share repurchase program cautions investors that forward-looking statements are subject to risks and uncertainties, including those detailed in HealthStream’s annual and other SEC filings. Actual results may differ materially from those implied or stated in forward-looking statements.

Disclaimer

This article is based on HealthStream, Inc.’s Form 8-K and related exhibits as filed with the SEC on March 13, 2026. The content is intended for informational purposes only and does not constitute investment advice. Investors should review official filings and consult their financial advisors before making investment decisions. The company undertakes no obligation to update or revise any forward-looking statements.

View HEALTHSTREAM INC Historical chart here